AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Retrospective Analysis of Acute Pancreatitis After Percutaneous Mechanical Thrombectomy In Treatment Of Thrombotic Disorders

Recruitingn/aAges 18 Years - anyAllRenJi Hospital
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Acute pancreatitis is a rare complication after percutaneous mechanical thrombectomy in treatment of thrombotic disorders. The objectives of this study include: (1) Determine the incidence and severity of acute pancreatitis after percutaneous mechanical thrombectomy; (2) Identify patient/procedural risk factors; (3) Evaluate clinical outcomes; (4) Develop a diagnosis and treatment pathway.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Patients over 18 years old; * Patients with thrombotic peripheral vascular diseases treated by percutaneous mechanical thrombectomy; * Patients developed acute pancreatitis within 14 days after percutaneous mechanical thrombectomy; * Patients with written informed consent. Exclusion Criteria: * Patients with acute pancreatitis attributed to other confirmed causes; * Patients unable or unwilling to participate in the study.
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

1 site
Renji Hospital
Shanghai, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy